[an error occurred while processing this directive]

Advanced Ultrasound in Diagnosis and Therapy ›› 2021, Vol. 5 ›› Issue (3): 254-257.doi: 10.37015/AUDT.2021.210018

• • 上一篇    下一篇

  

  • 收稿日期:2021-07-01 修回日期:2021-07-22 出版日期:2021-09-30 发布日期:2021-08-31

Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization

Esika Savsania, Mohamed Tantawi, MDa, Corinne E. Wessner, MBA, RDMS, RVTa, Philip Lee, MDa, Andrej Lyshchik, MD, PhDa, Kevin Anton, MD, PhDa, Colette M. Shaw, MDa, Ji-Bin Liu, MDa, John R. Eisenbrey, PhDa,*()   

  1. aDepartment of Radiology, Thomas Jefferson University, Philadelphia, PA, USA
  • Received:2021-07-01 Revised:2021-07-22 Online:2021-09-30 Published:2021-08-31
  • Contact: John R. Eisenbrey, PhD E-mail:John.eisenbrey@jefferson.edu

RichHTML

10

PDF (PC)

349

Abstract:

Minimally invasive locoregional therapies have become important treatment options for patients with intermediate or late-stage hepatocellular carcinoma (HCC) who are ineligible for surgical resection or liver transplantation. Imaging modalities are essential for procedural guidance and for assessing treatment response thereafter. We report a unique finding of a patient with multifocal HCC treated with transarterial radioembolization (TARE) with yttrium-90 (Y90) and transarterial chemoembolization (TACE). We compared contrast-enhanced ultrasound (CEUS) with contrast-enhanced magnetic resonance imaging (CE-MRI) in the evaluation of treatment response to demonstrate advantages of CEUS imaging technique and its early detection of viable tumor.

Key words: Contrast-enhanced ultrasound, Hepatocellular carcinoma, Transarterial radioembolization, Transarterial chemoembolization, Treatment response

[1] Cardarelli-Leite L, Hadjivassiliou A, Klass D, Chung J, Ho SGF, Lim HJ, et al. Current locoregional therapies and treatment strategies in hepatocellular carcinoma. Curr Oncol 2020; 27:s144-s151.
[2] Hibi T, Sugawara Y. Locoregional therapy as a bridge to liver transplantation for hepatocellular carcinoma within Milan criteria: from a transplant oncology viewpoint. Hepatobiliary Surg Nutr 2018; 7:134-135.
[3] Singh P, Anil G. Yttrium-90 radioembolization of liver tumors: what do the images tell us? Cancer Imaging 2014; 13:645-657.
[4] Raoul JL, Forner A, Bolondi L, Cheung TT, Kloeckner R, de Baere T. Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence. Cancer Treat Rev 2019; 72:28-36.
[5] Kirchner T, Marquardt S, Werncke T, Kirstein MM, Brunkhorst T, Wacker F, et al. Comparison of health-related quality of life after transarterial chemoembolization and transarterial radioembolization in patients with unresectable hepatocellular carcinoma. Abdom Radiol (NY) 2019; 44:1554-1561.
[6] Piscaglia F, Ogasawara S. Patient selection for transarterial chemoembolization in hepatocellular carcinoma: importance of benefit/risk assessment. Liver Cancer 2018; 7:104-119.
[7] Eisenbrey JR, Gabriel H, Savsani E, Lyshchik A. Contrast-enhanced ultrasound (CEUS) in HCC diagnosis and assessment of tumor response to locoregional therapies. Abdom Radiol (NY) 2021.
[8] Eisenbrey JR, Forsberg F, Wessner CE, Delaney LJ, Bradigan K, Gummadi S, et al. US-triggered microbubble destruction for augmenting hepatocellular carcinoma response to transarterial radioembolization: a randomized pilot clinical trial. Radiology 2021; 298:450-457.
[9] Dietrich CF, Averkiou M, Nielsen MB, Barr RG, Burns PN, Calliada F, et al. How to perform contrast-enhanced ultrasound (CEUS). Ultrasound Int Open 2018; 4:E2-e15.
[10] Wink MH, Wijkstra H, De La Rosette JJ, Grimbergen CA. Ultrasound imaging and contrast agents: a safe alternative to MRI? Minim Invasive Ther Allied Technol 2006; 15:93-100.
[11] Pang EHT, Chan A, Ho SG, Harris AC. Contrast-enhanced ultrasound of the liver: optimizing technique and clinical applications. AJR Am J Roentgenol 2018; 210:320-332.
[12] Xu E, Long Y, Li K, Zeng Q, Tan L, Luo L, et al. Comparison of CT/MRI-CEUS and US-CEUS fusion imaging techniques in the assessment of the thermal ablation of liver tumors. Int J Hyperthermia 2019; 35:159-167.
[13] Kudo M. Breakthrough imaging in hepatocellular carcinoma. Liver Cancer 2016; 5:47-54.
No related articles found!
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
[an error occurred while processing this directive]